Practical Reviews

Skin Synuclein Deposition Is Sensitive Biomarker for DLB

Key PickKey Reviews are selected for their clinical importance or significance and are marked with a key icon.

Background: Dementia with Lewy bodies (DLB), one of the synucleinopathies, is the second most common neurodegenerative dementia, with some unique clinical and treatment features. The diagnosis can be difficult at times. A specific and sensitive biomarker would be very useful, especially in the development of early disease-modifying therapy. Objective: To investigate whether phosphorylated α-synuclein (p-syn) skin-nerve deposition could be useful in differentiating DLB from ot more...
To view this content, you must be a logged in subscriber to
Please Login to view this content.